A single-arm, single-center clinical study of tislelizumab combined with bevacizumab and TAS-102 and SBRT (BETTER) in the treatment of MSS metastatic Colorectal cancer
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Interventions: Combined therapy group:Tislelizumab +TAS-102+ bevacizumab + stereotactic body radiotherapy Primary outcome(s): mPFS;ORR Study Design: Single arm
创建时间：
2023-09-15
